The Green Tea Polyphenol, Epigallocatechin-3-Gallate (EGCG)-One Step Forward in Antiviral Therapy Against Hepatitis C Virus

Journal of Clinical and Experimental Hepatology

Volumn 1, Issue 3, 2011, Pages 159-160

  Dhiman, Radha K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BOCEPREVIR; CD81 ANTIGEN; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; GLYCOPROTEIN E1; GLYCOPROTEIN E2; LOW DENSITY LIPOPROTEIN RECEPTOR; PEGINTERFERON ALPHA; PROTEINASE INHIBITOR; RIBAVIRIN; SILYMARIN; TELAPREVIR;

CELL SURFACE; DRUG CYTOTOXICITY; EDITORIAL; END STAGE LIVER DISEASE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REINFECTION; VIRION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS TRANSMISSION;

EID: 84856812678     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/S0973-6883(11)60232-6     Document Type: Editorial

References (12)

1. Shepard CW, Finelli L, Alter MJ Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005, 5:558-567.
2. Asselah T, Marcellin P New direct-acting antivirals' combination for the treatment of chronic hepatitis C. Liver Int 2011, 31(Suppl 1):68-77.
3. Ciesek S, von Hahn T, Colpitts CC, et al. The green tea poly-phenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology 2011, 54:1947-1955.
4. Calland N, Albecka A, Belouzard S, et al. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology 2011, [Epub ahead of print]. 10.1002/hep.24803.
5. Suganuma M, Saha A, Fujiki H New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sc/ 2011, 102:317-323.
6. Timpe JM, Stamataki Z, Jennings A, et al. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 2008, 47:17-24.
7. Maluf DG, Archer KJ, Villamil F, Stravitz RT, Mas V Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression. Expert Rev Gastroenterol Hepatol 2010, 4:445-458.
8. Marzano A The prevention of viral recurrence in the long term. Dig Liver Dis 2009, 41(Suppl 2):S195-S197.
9. Bartosch B, Dubuisson J Recent advances in Hepatitis C virus cell entry. Viruses 2010, 2:692-709.
10. Blanchard E, Belouzard S, Goueslain L, et al. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 2006, 80:6964-6972.
11. Wagoner J, Negash A, Kane OJ, et al. Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology 2010, 51:1912-1921.
12. Chow HH, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003, 9:3312-3319.